Treatment for rheumatic disorders.
Tindall
Elizabeth A
EA
Fox
David A
DA
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000191:economics*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D007267:Injections; D007349:Insurance, Health, Reimbursement; D006278:Medicare; D020097:Natriuretic Peptide, Brain / Q000627:therapeutic use; D016134:Organizational Policy; D012646:Self Administration / Q000191:economics; D012955:Societies, Medical; D014481:United States
D000911:Antibodies, Monoclonal; D020097:Natriuretic Peptide, Brain; D000069285:Infliximab